Shang J, Jiang H, Zhao Y, Yang J, Lin Y, Zhang N
J Transl Med. 2025; 23(1):263.
PMID: 40038757
PMC: 11877874.
DOI: 10.1186/s12967-025-06316-6.
Patte C, Pommier R, Ferrari A, Chung F, Ouzounova M, Moulle P
Nat Commun. 2025; 16(1):2197.
PMID: 40038310
PMC: 11880452.
DOI: 10.1038/s41467-025-57305-8.
Wu D, Qiu H, Xu J, Lin J, Qian J
Front Immunol. 2025; 16:1490330.
PMID: 40034691
PMC: 11873079.
DOI: 10.3389/fimmu.2025.1490330.
Xu J, You Z, Zhu Z, Liu M, Zhang Z, Xu P
Front Immunol. 2025; 16:1520070.
PMID: 40018039
PMC: 11864954.
DOI: 10.3389/fimmu.2025.1520070.
Liu J, Yao L, Yang Y, Ma J, You R, Yu Z
J Transl Med. 2025; 23(1):238.
PMID: 40016772
PMC: 11869577.
DOI: 10.1186/s12967-025-06251-6.
A pan-cancer analysis of the oncogenic and immunological roles of RGS5 in clear cell renal cell carcinomas based on in vitro experiment validation.
Zhang Y, Wang H, Dai F, He K, Tuo Z, Wang J
Hum Genomics. 2025; 19(1):14.
PMID: 39985100
PMC: 11846387.
DOI: 10.1186/s40246-025-00717-w.
Predicting immunotherapy prognosis and targeted therapy sensitivity of colon cancer based on a CAF-related molecular signature.
Ying L, Zhang L, Chen Y, Huang C, Zhou J, Xie J
Sci Rep. 2025; 15(1):6387.
PMID: 39984646
PMC: 11845748.
DOI: 10.1038/s41598-025-90899-z.
Transcriptome analysis of ovarian cancer uncovers association between tumor-related inflammation/immunity and patient outcome.
Wang J, Zhu W, Li X, Wu Y, Ma W, Wang Y
Front Pharmacol. 2025; 16:1500251.
PMID: 39981173
PMC: 11839622.
DOI: 10.3389/fphar.2025.1500251.
Integrative analysis of T cell-mediated tumor killing-related genes reveals KIF11 as a novel therapeutic target in esophageal squamous cell carcinoma.
Cheng X, Zhao H, Li Z, Yan L, Min Q, Wu Q
J Transl Med. 2025; 23(1):197.
PMID: 39966857
PMC: 11834232.
DOI: 10.1186/s12967-025-06178-y.
Using major histocompatibility complex (MHC) II expression to predict antitumor response to CD4 + lymphocyte depletion.
Wang Y, Kim M, Su S, Halwatura L, You S, Kim H
Sci Rep. 2025; 15(1):5469.
PMID: 39953106
PMC: 11828847.
DOI: 10.1038/s41598-025-88972-8.
Unveiling the crucial role of glycosylation modification in lung adenocarcinoma metastasis through artificial neural network-based spatial multi-omics single-cell analysis and Mendelian randomization.
Zhang P, Wang L, Liu H, Lin S, Guo D
BMC Cancer. 2025; 25(1):249.
PMID: 39948531
PMC: 11823056.
DOI: 10.1186/s12885-025-13650-x.
Comprehensive single-cell pan-cancer atlas unveils IFI30+ macrophages as key modulators of intra-tumoral immune dynamics.
Jiang L, Wang P, Hou Y, Chen J, Li H
Front Immunol. 2025; 16:1523854.
PMID: 39925804
PMC: 11802554.
DOI: 10.3389/fimmu.2025.1523854.
Integrative analysis of SEPN1 in glioma: Prognostic roles, functional implications, and potential therapeutic interventions.
Wang Z, Wang D, Wang X, Xu Y, Yuan Y, Chen Y
PLoS One. 2025; 20(2):e0318501.
PMID: 39919065
PMC: 11805447.
DOI: 10.1371/journal.pone.0318501.
A new signature associated with anoikis predicts the outcome and immune infiltration in nasopharyngeal carcinoma.
Luo Y, Wei W, Huang Y, Li J, Qin W, Hao Q
Discov Oncol. 2025; 16(1):123.
PMID: 39913001
PMC: 11802990.
DOI: 10.1007/s12672-025-01869-w.
Immune regulatory genes impact the hot/cold tumor microenvironment, affecting cancer treatment and patient outcomes.
Sang M, Ge J, Ge J, Tang G, Wang Q, Wu J
Front Immunol. 2025; 15:1382842.
PMID: 39911580
PMC: 11794490.
DOI: 10.3389/fimmu.2024.1382842.
Multiple machine learning-based integrations of multi-omics data to identify molecular subtypes and construct a prognostic model for HNSCC.
Luo X, Li C, Qin G
Hereditas. 2025; 162(1):17.
PMID: 39910672
PMC: 11800565.
DOI: 10.1186/s41065-025-00380-0.
ZC3H12D upregulation in head and neck squamous cell carcinoma: a potential prognostic biomarker associated with immune infiltration.
Zhao M, Huang W, Huang X, Gu F, Yang L, Wang Y
Braz J Med Biol Res. 2025; 58:e14227.
PMID: 39907408
PMC: 11793147.
DOI: 10.1590/1414-431X2024e14227.
Integrative analysis of immunogenic PANoptosis and experimental validation of cinobufagin-induced activation to enhance glioma immunotherapy.
Cai Y, Xiao H, Xue S, Li P, Zhan Z, Lin J
J Exp Clin Cancer Res. 2025; 44(1):35.
PMID: 39901195
PMC: 11789371.
DOI: 10.1186/s13046-025-03301-1.
Disulfidptosis-related gene signatures as prognostic biomarkers and predictors of immunotherapy response in HNSCC.
Qin H, Xu J, Yue Y, Chen M, Zhang Z, Xu P
Front Immunol. 2025; 15:1456649.
PMID: 39896807
PMC: 11782277.
DOI: 10.3389/fimmu.2024.1456649.
Transcriptomic Profiling and Tumor Microenvironment Classification Reveal Unique and Dynamic Immune Biology in HIV-Associated Kaposi Sarcoma.
Yang J, Cali Daylan A, Shevkoplias A, Postovalova E, Wang M, Tyshevich A
Cells. 2025; 14(2).
PMID: 39851562
PMC: 11764145.
DOI: 10.3390/cells14020134.